[
    [
        {
            "time": "2018-03-15",
            "original_text": "Roche Tecentriq Phase III Combo Study Meets Primary Endpoint",
            "features": {
                "keywords": [
                    "Roche",
                    "Tecentriq",
                    "Phase III",
                    "Combo",
                    "Study",
                    "Meets",
                    "Primary",
                    "Endpoint"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Roche Tecentriq Phase III Combo Study Meets Primary Endpoint",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-04-10",
            "original_text": "CVS appoints former Eli Lilly CFO as president of PBM business",
            "features": {
                "keywords": [
                    "CVS",
                    "appoints",
                    "former",
                    "Eli Lilly",
                    "CFO",
                    "president",
                    "PBM",
                    "business"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmacy"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "CVS appoints former Eli Lilly CFO as president of PBM business",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-05-20",
            "original_text": "Understanding Nektar Therapeutics’ Top-Line Performance",
            "features": {
                "keywords": [
                    "Nektar",
                    "Therapeutics",
                    "Top-Line",
                    "Performance"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Understanding Nektar Therapeutics’ Top-Line Performance",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-06-05",
            "original_text": "CVS to Hire Former Eli Lilly CFO to Run Pharmacy Benefit Business",
            "features": {
                "keywords": [
                    "CVS",
                    "Hire",
                    "Former",
                    "Eli Lilly",
                    "CFO",
                    "Run",
                    "Pharmacy",
                    "Benefit",
                    "Business"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmacy"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "CVS to Hire Former Eli Lilly CFO to Run Pharmacy Benefit Business",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-07-12",
            "original_text": "3 High-Quality Dividend-Payers Selling at a Discount",
            "features": {
                "keywords": [
                    "High-Quality",
                    "Dividend-Payers",
                    "Selling",
                    "Discount"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance",
                    "investing"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "3 High-Quality Dividend-Payers Selling at a Discount",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]